Two Neds better than one in Jupiter’s world of moons

A pair of industry veterans have teamed up to create Jupiter Bioventures, a San Francisco-based biotech venture foundry promised to build bold, science-driven therapeutics companies.

Nathaniel ‘Ned’ David previously co-founded Syrrx, Achaogen, Kythera Biopharmaceuticals and UNITY Biotechnology, while Norman ‘Ned’ Sharpless was previously director of both the National Cancer Institute and UNC’s Lineberger Comprehensive Cancer Center, acting commissioner of the US Food and Drug Administration, and was a co-founder of G1 Therapeutics. 

Between them, Dr Sharpless and Dr David’s previous companies have generated five approved medicines, four IPOs and three corporate acquisitions.